The IDPC Drug Policy Guide brings together global evidence, best practice and experiences to provide expert analysis across the spectrum of drug policy.
This IDPC advocacy note raises some persisting concerns and proposes some additional comments and recommendations intended to support the ongoing negotiations process around the UNGASS outcome document.
Current negotiations on global drug policy reform are failing to address human rights, health and security crisis according to a new Global Commission statement on UNGASS 2016.
This IDPC briefing paper examines several of the most prominent themes to emerge from the contributions of 15 UN entities and their progress into the UNGASS debates.
In this report, IDPC offers recommendations based on evidence and examples of good practice to inform a shift in policy responses to drug use in Asia away from criminalisation and punishment, and towards public health and harm reduction.
Over the last decade, harm reduction has proved to be an approach to drugs that saves lives, saves money, and helps respect, protect and fulfil the human rights of people who use drugs.
